• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

SBI Gold ETF
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
590098
INF200KA16D8
1
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SETFGOLD
0
17838.5
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

Ipca Laboratories consolidated net profit rises 31.49% in the December 2025 quarter
Feb 13,2026
Net profit of Ipca Laboratories rose 31.49% to Rs 326.27 crore in the quarter ended December 2025 as against Rs 248.14 crore during the previous quarter ended December 2024. Sales rose 6.55% to Rs 2392.50 crore in the quarter ended December 2025 as against Rs 2245.37 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales2392.502245.37 7
OPM %22.2920.62 -
PBDT535.92466.38 15
PBT428.33367.92 16
NP326.27248.14 31